The Iris-1 Lenses
Neural-Sync
Our proprietary interface translates neural signals into digital commands. It allows for hands-free interaction with a latency of less than 15ms. Your thoughts control the flow of information.
8K Overlay
Using Nano-LED technology, we project high-fidelity data directly onto the retina. Whether it's complex architectural blueprints or simple navigation, the image remains stable and crystal clear.
Bio-Liquid
The lens adapts its curvature in real-time, mirroring the natural eye's crystalline lens. It provides infinite autofocus, eliminating digital eye strain and blurred vision for the user.
*Iris-1 is currently undergoing final beta testing with industrial partners in surgery and aerospace.
Strategic Roadmap
Market Entry
Commercial launch of the Iris-1. We target 2 million units sold in Year 1 to generate the capital necessary for Phase 2. High-volume production starts in Q3.
Bio-Medical
Expanding into health-tech. Our sensors will monitor glucose, blood pressure, and ocular fatigue. This phase establishes our credibility with global healthcare regulators.
Project Lazarus
The ultimate goal: A total ocular replacement. By connecting digital sensors directly to the optic nerve, we aim to eliminate visual impairment and restore sight to millions.
Executive Board
Renald sonnet
Chief Executive OfficerSpecialized in Neural Systems and Business Strategy. Leading the transition from consumer electronics to large-scale medical disruption.
Baddredine zaidi
Chief Technology OfficerLead architect in Bio-Nanotechnology. Expert in optic nerve signal processing and proprietary hardware encryption protocols.
"Innovating today to see tomorrow."